D-dimer for patients on VKA vs DOAC: impact on the validity of D-dimer to make decision for extended anticoagulation

Blood Adv. 2024 Jul 23;8(14):3612-3614. doi: 10.1182/bloodadvances.2024013193.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anticoagulants* / therapeutic use
  • Female
  • Fibrin Fibrinogen Degradation Products* / analysis
  • Humans
  • Male
  • Vitamin K / antagonists & inhibitors

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Anticoagulants
  • Vitamin K